Sort
16,300 grants matching “fatty liver disease”
Biospecimen & Biomarker Development Core
$68,513Michael E. Scheurer · Baylor College Of Medicine · P01 · FY2024 · CA
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer
$68,468Mary Christine Playdon · Utah State Higher Education System--University Of Utah · U01 · FY2025 · CA
Subclinical and clinical heart disease and the effect on kidney injury and diseas
$68,450Meyeon Park · University Of California, San Francisco · F32 · FY2011 · DK
Fatty Liver Disease in African Americans
$68,291Somiranjan Ghosh · Howard University · P20 · FY2020 · CA
Identification of Organ-Specific Small Extracellular Vesicles in Mouse Serum
$68,188Myriam Gorospe · National Institute On Aging · ZIA · FY2025 · AG
Freezer Supplement to Hepatobiology and Toxicology COBRE
$68,000Craig J McClain · University Of Louisville · P20 · FY2022 · GM
Activation of Atypical PKC by Insulin and Other Agonists
$67,976Robert V Farese · Roskamp Institute, Inc. · R01 · FY2012 · DK
Immunopathogenesis of non-alcoholic fatty liver disease
$67,836Senad Divanovic · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · DK
Immunopathogenesis of non-alcoholic fatty liver disease
$67,836Senad Divanovic · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · DK
Cardiometabolic effects of genetically decreased dipeptidyl peptidase-4 (DPP4)
$67,824Jessica Rose Wilson · University Of Pennsylvania · K23 · FY2021 · HL
Reducing the burden of chronic inflammation through dietary integration of Moringa oleifera
$67,740Carrie Waterman · Rutgers, The State Univ Of N.J. · K01 · FY2015 · TW
Etiology and impact of ethnic disparities in therapy-associated hepatotoxicity among children and adolescents treated for ALL
$67,644Austin L Brown · Baylor College Of Medicine · P20 · FY2023 · CA
Elucidating novel molecular mechanisms of irisin-mediated effects via integrin
$67,582Mu A · Dana-Farber Cancer Inst · F32 · FY2022 · DK
Defining intracellular mitochondrial heterogeneity establishment and maintenance
$67,582Corey Nathaniel Cunningham · University Of Utah · F32 · FY2022 · GM
Associations between Gut Microbiota, Plasma Metabolites, and Metabolic Syndrome Traits
$67,582Sahereh Mirzaei · University Of California Los Angeles · F32 · FY2022 · NR
Administrative Core
$67,550Robert H Tukey · University Of California, San Diego · P42 · FY2019 · ES
Phase 3 Trial: Standard vs Reduced IV Fat for PNAC Preventiion (IND 121287) 2/2014
$67,529Meghan Alexa Arnold · University Of Michigan At Ann Arbor · R01 · FY2019 · FD
Pilot Trial UO1 DUR-928
$67,470Craig J McClain · University Of Louisville · U01 · FY2022 · AA
Tunable Synthetic ECMs for Investigating Stellate Cell Activation and Migration
$67,446Matthew David Davidson · University Of Pennsylvania · F32 · FY2020 · DK
Regulation of body weight, energy expenditure, and nutrient metabolism by hypothalamic Slug (Snai2) neural circuits
$67,446Min Hyun Kim · University Of Michigan At Ann Arbor · F32 · FY2020 · DK
Engineered Probiotics and Bile Acid Metabolism in the Gut Microbiome
$67,410Steven David Brown · University Of California, San Diego · F32 · FY2017 · DK
Site-1 Protease in the regulation of skeletal muscle metabolism and exercise endurance
$67,390Rita Thomas Brookheart · Washington University · K01 · FY2023 · HL
Role of Intestinal Microbiota in Dyslipidemia and Atherosclerosis Induced by Ambient Ultrafine Particles
$67,266Jesus Antonio Araujo · University Of California Los Angeles · R01 · FY2021 · ES
Effect of Organophoshate Exposure on Cholesteryl Ester Hydrolase
$67,200Matthew K Ross · Mississippi State University · R15 · FY2009 · ES
Understanding the regulation of ER GPATs to control glycerolipid synthesis in disease
$67,174Timothy Cole Kenny · Rockefeller University · F32 · FY2022 · DK